NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Unravel Health

Unravel Health

Private
LondonHealthcare & Life Scienceshttps://unravel.health/

Last Round

Grant

Feb 20, 2025

Total Funding Raised

$161,250

Company Overview

Unravel Health is a health technology company that develops a non-invasive, at-home saliva monitoring device to track hormonal patterns and biomarkers for women's health.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics, Health IoT, D2C Brands, Sensors

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

femtechat-home hormone testingsaliva monitoringhormonal healthbiomarker trackingwomen's health techdiagnostic hardwarehealth IoTpersonalized health insightshormone analyticsPCOS managementperimenopause trackingdigital healthdata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Unravel Health Comps

Public and private peers based on sector, stage, and business model.

Unravel Health comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Unravel Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 20, 2025
AcceleratorDec 3, 2024
AcceleratorOct 25, 2024

Unravel Health Investors

Notable investors and investment history

Unravel Health investors
InvestorRounds
STACAccelerator
University of GlasgowAccelerator
SBRI HealthcareGrant
Health Innovation NetworkGrant
NHS Accelerated Access CollaborativeGrant
Central Research LaboratoryAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 22, 2024

    Grew 150% QoQ from 2 to 5 employees.

Unravel Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Unravel Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Unravel Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range9
Year Founded2024
Last FundingFeb 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.